Nicholas Piramal Limited - Intergrating Diversity
Subject
Strategy and Entrepreneurship, Strategy and Entrepreneurship
Publication Year
2002
Abstract
In rapidly deregulating markets, merger and acquisition driven growth represents one attractive strategic option. This option however comes with its well-known risks and dangers. Nicholas Piramal has grown phenomenally over the 1990's, emerging as a major pharmaceutical company in India, by adopting such a strategy. Over this decade, it has acquired the Indian operations of several well known pharmaceutical multinationals including Hoffman - La Roche, Boehringer Mannheim and the R&D unit of Hoechst. The case describes how the company has managed each of these acquisitions - all the way from the deal making to the post-acquisition integration phases. However, while the individual acquisitions only created the platform, sustained growth required that all the acquired units be integrated in an overall unified organisation. The case also describes how Nicholas Piramal developed such an organisation in 1997 and the structures, management processes and leadership it put in place to ensure effective functioning of the total company.
Topic List
Growth, Mergers & Acquistion, Strategies in emerging markets
Industry
Pharmaceuticals
Publication Event Date
2000
LBS Case Number
CS-02-003
Location
India
Publication Organisation Size
$420 million in revenues
Project Funder
ESRC
Available on ECCH
No
